- Home
- CMTV vs ACIU Comparison
CMTV vs ACIU Comparison
Compare CMTV & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CMTV | ACIU |
|---|---|---|
| Founded | N/A | 2003 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 219.5M | 247.6M |
| IPO Year | 1995 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CMTV | ACIU |
|---|---|---|
| Price | $41.05 | $2.53 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 30.4K | ★ 197.1K |
| Earning Date | N/A | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.02 | N/A |
| EPS | ★ 1.62 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $706.75 |
| Revenue Next Year | N/A | $321.13 |
| P/E Ratio | $25.05 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $29.53 | $2.03 |
| 52 Week High | $43.76 | $4.00 |
Technical Indicators
Market Signals| Indicator | CMTV | ACIU |
|---|---|---|
| Relative Strength Index (RSI) | 53.67 | 55.88 |
| Support Level | $38.56 | $2.51 |
| Resistance Level | $41.72 | $2.68 |
| Average True Range (ATR) | 1.85 | 0.12 |
| MACD | 0.07 | 0.03 |
| Stochastic Oscillator | 50.73 | 67.31 |
Price Performance
Historical ComparisonAbout CMTV Community Bancorp. (VT)
Community Bancorp Inc is a holding company that provides a complete line of personal and business banking services with personal services and solutions. The company mainly offers Business banking, Commercial real estate lending, residential real estate lending, Retail credit, Municipal and Institutional Banking, and Retail Banking. The company's primary lending products are commercial, real estate, municipal, and consumer loans. The bank offers a complete line of personal and business products and services, along with offerings for non-profit organizations, municipalities, and local governments. The Firm also engages in lending activity outside the area of its branch network, through loan production offices in Burlington, Vermont, and Lebanon, New Hampshire.
About ACIU AC Immune SA
AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.